# Hasmukh Jain

Source: https://onco.cc/people/jain-hasmukh/  
OnCo record `jain-hasmukh` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

First author of the phase 1/2 trial of India's first CAR-T therapy, which treated adults with relapsed lymphoma and leukaemia at six Indian centres.

## Summary

Hasmukh Jain is a haematolymphoid medical oncologist at Tata Memorial Hospital and first author of the Lancet Haematology report of talicabtagene autoleucel (NexCAR19) in relapsed or refractory B-cell malignancies: 64 patients were enrolled across phase 1 and 2 at six tertiary centres, with an overall response rate of 73% in 51 evaluable patients and two treatment-related deaths. He runs lymphoma and CAR-T programmes at Tata Memorial and is an investigator on Indian and international lymphoma trials.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Role: Professor of Medical Oncology (adult haematolymphoid), Tata Memorial Hospital
- Specialisms: Lymphoma; Acute leukaemia; CAR-T cell therapy; Clinical trials

## Sources

- Tata Memorial Centre: https://tmc.gov.in
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Jain%20H%5BAuthor%5D%20Tata%20Memorial%20lymphoma%20CAR

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/)
- targets: [CD19](https://onco.cc/targets/cd19/)
- drugs: [Talicabtagene autoleucel](https://onco.cc/drugs/talicabtagene-autoleucel/)
- institutions: [Tata Memorial Centre](https://onco.cc/institutions/tata-memorial/)
- trials: [Talicabtagene autoleucel (NexCAR19) phase 1/2](https://onco.cc/trials/talicel-phase-1-2/)
- key papers: [Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: an open-label, multicentre, phase 1/2 study](https://onco.cc/key-papers/paper-jain-talicabtagene-lancet-haem-2025/)
- companies: [ImmunoACT](https://onco.cc/companies/immunoact/)

---
JSON: https://onco.cc/api/v1/entities/jain-hasmukh.json